US2012214810A1PendingUtilityA1

Salts of N-[6-cis-2,6-Dimethylmorpholin-4-yl)pyridine-3-yl]-2-methyl-4'-(trifluoromethoxy)[1,1'-biphenyl]-3-carboxamide

51
Assignee: BAJWA JOGINDER SINGHPriority: Sep 17, 2008Filed: May 2, 2012Published: Aug 23, 2012
Est. expirySep 17, 2028(~2.2 yrs left)· nominal 20-yr term from priority
Inventors:Joginder S. BajwaMarilyn De La CruzStephanie Kay DoddLiladhar Murlidhar WaykoleRaeann Wu
A61P 43/00A61P 35/02A61P 35/00C07D 413/04A61K 31/5377A61K 35/00
51
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

Salts of N-[6-(cis-2,6-dimethylmorpholin-4-yl)pyridine-3-yl]-2-methyl-4′-(trifluoromethoxy)[1,1′-biphenyl]-3-carboxamide are prepared and characterized.

Claims

exact text as granted — not AI-modified
1 . A mono sulfate salt of N-[6-(cis-2,6-dimethylmorpholin-4-yl)pyridine-3-yl]-2-methyl-4′-(trifluoromethoxy)[1,1′-biphenyl]-3-carboxamide. 
     
     
         2 . A pharmaceutical composition comprising:
 (a) a therapeutically effective amount of a salt according to  claim 1 ; and   (b) at least one pharmaceutically acceptable carrier, diluent, vehicle or excipient.

Join the waitlist — get patent alerts

Track US2012214810A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.